Adenosine deaminase activity in estrogen receptor positive and negative human breast cancer cell lines

Medical Journal of the Islamic Republic of Iran

Volumn 19, Issue 1, 2005, Pages 53-56

  Hashemi, Mohammad ^a,d   Tehrani, Fatemeh Karami ^b   Ghavami, Saeid ^a   Sabet, Majid Sirati ^c  

^a ZAHEDAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TARBIAT MODARES UNIVERSITY   (Iran)

^c QAZVIN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d ZAHEDAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Adenosine deaminase; Breast cancer cell lines; Estrogen receptor

Indexed keywords

ADENOSINE DEAMINASE; CHARCOAL; DIETHYLSTILBESTROL; ESTROGEN RECEPTOR; TAMOXIFEN;

ARTICLE; BREAST CANCER; CALORIMETRY; CANCER CELL CULTURE; CONTROLLED STUDY; CULTURE MEDIUM; ENZYME ACTIVITY; HUMAN; HUMAN CELL;

EID: 33846209257     PISSN: 10161430     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Wilson DK, Rudoloh FB, Quiocho FA: Atomic structure of adenosine deaminase complexed with a transition-state analog: Understanding catalysis and immunodeficiency mutation. Science 252: 1276-1284, 1991.
2. Van der Weyden MB, Kelley WN: Human adenosine deaminase. Distribution and properties. J Biol Chem 251: 5446-5456, 1976.
3. Adams A, Harkness RA: Adenosine deaminase activity in thymus and other human tissues. Clin Exp Immunol 26: 647-649, 1976.
4. Chechik BE, Schreder WR Minowada J: An immunomorphological study of adenosine deaminase distribution in human thymus tissue, normal lymphocytes, and hematopoietic cell lines. J Immunol 126: 1003-1007, 1981.
5. Resta R, Thompson LF: SCID: The role of adenosine deaminase deficiency. Immunology Today 18: 371-374, 1997.
6. Koizumi H, Lizuka H, Auyagi T, Miura Y: Characterization of adenosine deaminase from human epidermis and squamous cell carcinoma of the skin. J Inv Derm 84: 199-202, 1985.
7. Camici M, Tozzi MG, Allergrini Del Corso A, Sanfilippo O, Daidone MG, De Marco C, Ipata PL: Purine salvage enzyme activity in normal and neoplastic human tissues. Cancer Biochem Biophys 11: 201-209, 1990.
8. Sufrin G, Tritsch GL, Mittelman A, Murphy GP: Adenosine deaminase in patients with carcinoma of bladder. J Urol 119: 343-346, 1978.
9. Durak I, Isik AU, Canbolat O, Akyol O, Kavutcu M: Adenosine deaminase, 5′ nucleotidase, superoxide dismutase and catalase activities in cancerous and non-cancerous human laryngeal tissues. Free Radic Biol Med 15: 681-684, 1993.
10. Aitken SC, Lippman ME: Hormonal regulation of de novo pyrimidine synthesis and utilization in human breast cancer cells in tissue culture. Cancer Res 43: 4681-4690, 1983.
11. Aitken SC, Lippman ME, Kasid A, Schoenberg DR: Relationship between the expression of estrogen-regulated genes and estrogen-stimulated proliferation of MCF-7 mammary tumor cells. Cancer Res 45: 2608-2615, 1985
12. Aitken SC, Lippman ME: Effect of estrogen and antiestrogens on growth-regulatory enzymes in human breast cancer cells in tissue culture. Cancer Res 45: 1611-1620, 1985.
13. Cowan K, Levine R, Aitken S, Goldsmith M, Douglass E, Clendeninn N, Nienhuis A, Lippman ME: Dihydrofolate reductase gene amplification and possible rearrangement in estrogen-responsive methotrexate resistant human breast cancer cells. J Biol Chem 257: 15079-15086, 1982.
14. Kasid A, Davidson NE, Gelmann EP, Lippman ME: Transcriptional control of thymidine kinase gene expression by estrogens and antiestrogens in MCF-7 human breast cancer cells. J Biol Chem 261: 5562-5567, 1986.
15. Xie W, Duan R, Safe S: Estrogen induces adenosine deaminase gene expression in MCF-7 human breast cancer cells: Role of oestrogen receptor-Sp1 interactions. Endocrinology 140: 219-227, 1999.
16. Guisti, G, Galanti, B. Colorimetric method. In: Bergmeyer HU (ed). Methods of enzymatic analysis. Verlag Chemie, Weinheim, pp. 315-323, 1984.
17. Bradford MM: A rapid and sensitive method for the quantities of microgram of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254, 1976.
18. Ballett JJ, Insel R, Merler E, Ronsen FS: Inhibition of maturation of human precursor lymphocyte by coformycin, an inhibitor of the enzyme adenosine deaminase. J Exp Med 143: 1271-1276, 1976.
19. Havi T, Smyth JF, Allison AC, Williams SCW: Role of adenosine deaminase in lymphocyte proliferation. Clin Exp Immunol 23: 395-403, 1976
20. Durak I, Beduk Y, Kavutcu M, Suzer O, Yaman O, Ozturk HS, Canbolat O, Ulutepe S: Activity of the enzymes participating in purine metabolism of cancerous and noncancerous human kidney tissues. Cancer Invest 15: 212-216, 1997.
21. Namiot Z, Stasiewicz A, Namiot A, Keomona A, Kraliz M, Gorski J: Adenosine deaminase activity in patients with the intestinal type of gastric carcinoma. Cancer Letters 109: 199-202, 1996.
22. Canbolat O, Durak I, Cetin R, Kavutku M, Dermirci S, Ozturk S: Activities of adenosine deaminase, 5′-nucleotidase, guanase, and cytidine deaminase enzyme in cancerous and non-cancerous human breast tissues. Breast Cancer Res Treat 37: 189-193, 1996.
23. Salami S, Karami Tehrani F: Biochemical studies of apoptosis induced by tamoxifen in estrogen receptor positive and negative breast cancer cell lines. Clinical Biochem 36: 247-253, 2003.